US Patent Issued to OVID THERAPEUTICS on Oct. 20 for "Methods of treating seizure disorders and Prader-Willi syndrome" (Connecticut Inventor)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,119, issued on Oct. 20, was assigned to OVID THERAPEUTICS INC. (New York).

"Methods of treating seizure disorders and Prader-Willi syndrome" was invented by Matthew During (Darien, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating a seizure disorder with (1S,3S)-3-amino-4-(difluoromethylidene)cyclopentane-1-carboxylic acid, or (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid (KT-II-115), or a pharmaceutically acceptable salt of any of the preceding, are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of a seizure disorder. Methods of treating Prader-Wil...